Pharmacokinetics, Safety, and Tolerability of Single-Dose Elbasvir in Participants with Hepatic Impairment

2018

Background The combination of elbasvir and grazoprevir is approved for the treatment of hepatitis C virus genotype 1 or 4 infection.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

19

References

5

Citations